首页> 美国卫生研究院文献>British Journal of Cancer >Prediction of survival and recurrence by serum and cytosolic levels of CEA CA125 and SCC antigens in resectable non-small-cell lung cancer.
【2h】

Prediction of survival and recurrence by serum and cytosolic levels of CEA CA125 and SCC antigens in resectable non-small-cell lung cancer.

机译:通过血清和胞浆中CEACA125和SCC抗原的血清和胞浆水平预测可切除的非小细胞肺癌的生存率和复发率。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Risk of death and risk of recurrence in 108 potentially curable non-small-cell lung cancer patients were analysed with respect of TNM stage, histological type and carcinoembryonic antigen (CEA), CA125 antigen and squamous cell carcinoma antigen (SCC) levels in serum and cytosol. CA125 and CEA levels were closely related to outcome figures. Multivariate analyses indicated that TNM stage and histological type had the best predictive power, but serum and cytosolic CA125 and serum CEA contained additional, independent prognostic information. Predictive information drawn from serum and cytosolic levels proved mutually complementary. We conclude that CA125 and CEA complement TNM classification and histological type for the purpose of quantifying risk of death or recurrence.
机译:分析了108例潜在可治愈的非小细胞肺癌患者的死亡风险和复发风险,分析了TNM分期,组织学类型和癌胚抗原(CEA),CA125抗原和鳞状细胞癌抗原(SCC)的水平,胞质溶胶。 CA125和CEA水平与结果数字密切相关。多变量分析表明,TNM分期和组织学类型具有最佳的预测能力,但血清和胞浆CA125和血清CEA包含其他独立的预后信息。从血清和胞浆水平得出的预测信息证明是相互补充的。我们得出结论,CA125和CEA是TNM分类和组织学类型的补充,目的是量化死亡或复发的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号